Clinical trial
Curcumin for the Chemoprevention of Colorectal Cancer
NCT00118989 · University of Pennsylvania, Other · Terminated
Key facts
| NCT number | NCT00118989 |
|---|---|
| Title | Curcumin for the Chemoprevention of Colorectal Cancer |
| Official title | Phase II Double Blind Placebo-Controlled Trial of Curcuminoids' Effect on Cellular Proliferation, Apoptosis and COX-2 Expression in the Colorectal Mucosa of Subjects With Recently Resected Sporadic Adenomatous Polyps |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | Robert Wood Johnson Foundation |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Adenomatous Polyps |
| Intervention type | Dietary Supplement |
| Interventions | Curcuminoids |
| Enrollment | 56 |
| Start date | Jul 1, 2005 |
| Primary completion | Sep 1, 2010 |
| Completion | Jul 1, 2012 |
| First posted | Jul 12, 2005 |
| Last update posted | Apr 20, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: